PMN Valuation
ProMIS Neurosciences Inc
$
0.632
- Overview
- Forecast
- Valuation
PMN Relative Valuation
PMN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PMN is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.16
P/B
Median3y
42.71
Median5y
8.73
-137.88
FCF Yield
Median3y
-51.30
Median5y
-35.40
Competitors Valuation Multiple
The average P/S ratio for PMN's competitors is 0.86, providing a benchmark for relative valuation. ProMIS Neurosciences Inc Corp (PMN) exhibits a P/S ratio of 2.72, which is 216.03% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch
BOC
Boston Omaha Corp
15.370
USD
-1.03%
EAF
GrafTech International Ltd
0.631
USD
-0.32%
TRML
Tourmaline Bio Inc
16.780
USD
-2.50%
RICK
RCI Hospitality Holdings Inc
40.870
USD
+3.00%
MLYS
Mineralys Therapeutics Inc
14.920
USD
+5.00%
KRNY
Kearny Financial Corp
6.270
USD
+0.16%
GFR
Greenfire Resources Ltd
4.750
USD
+1.93%
VLGEA
Village Super Market Inc
36.740
USD
-0.30%
HIVE
HIVE Digital Technologies Ltd
1.820
USD
+7.69%
BBCP
Concrete Pumping Holdings Inc
6.140
USD
+2.33%
FAQ
Is ProMIS Neurosciences Inc (PMN) currently overvalued or undervalued?
ProMIS Neurosciences Inc (PMN) is now in the Fair zone, suggesting that its current forward PS ratio of 2.72 is considered Fairly compared with the five-year average of 2118.14. The fair price of ProMIS Neurosciences Inc (PMN) is between to according to relative valuation methord.
What is ProMIS Neurosciences Inc (PMN) fair value?
How does PMN's valuation metrics compare to the industry average?
What is the current P/B ratio for ProMIS Neurosciences Inc (PMN) as of May 01 2025?
What is the current FCF Yield for ProMIS Neurosciences Inc (PMN) as of May 01 2025?
What is the current Forward P/E ratio for ProMIS Neurosciences Inc (PMN) as of May 01 2025?